Grey Wolf Health Corp. (TSXV:WOLF)
Canada · Delayed Price · Currency is CAD 1.620
-0.110 (-6.36%)
Sep 10, 2026, 10:30 AM EST
Grey Wolf Health Ratios and Metrics
Market cap in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 60 | 45 | 38 | 23 | 24 | 4 | |
Market Cap Growth | 33.79% | 18.92% | 65.28% | -5.13% | 536.98% | - |
Enterprise Value | 75 | 64 | 40 | 25 | 47 | - |
Last Close Price | 1.73 | 1.32 | 1.11 | 0.74 | 0.78 | 1.58 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 38.91 | 27.24 | 53.86 | 37.67 | 9.52 | - |
PS Ratio | 1.59 | 1.26 | 1.42 | 0.90 | 1.07 | 0.29 |
PB Ratio | 1.89 | 1.48 | 1.32 | 0.92 | 1.00 | 0.93 |
P/TBV Ratio | - | - | - | 13.71 | - | - |
P/FCF Ratio | 13.55 | 13.63 | 31.30 | 10.68 | - | 1.79 |
P/OCF Ratio | 11.88 | 11.78 | 21.73 | 9.44 | - | 1.78 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.00 | 1.79 | 1.50 | 0.99 | 2.06 | - |
EV/EBITDA Ratio | 10.97 | 9.52 | 11.60 | 8.65 | 42.94 | - |
EV/EBIT Ratio | 18.22 | 15.12 | 19.78 | 15.21 | - | - |
EV/FCF Ratio | 17.06 | 19.35 | 33.09 | 11.74 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.77 | 0.83 | 0.96 | 0.40 | 0.46 | 5.90 |
Debt / EBITDA Ratio | 3.55 | 3.67 | 7.76 | 3.19 | 8.65 | 19.15 |
Debt / FCF Ratio | 5.52 | 7.69 | 22.76 | 4.62 | - | 11.32 |
Net Debt / Equity Ratio | 0.49 | 0.58 | 0.74 | 0.09 | 0.17 | 4.83 |
Net Debt / EBITDA Ratio | 2.38 | 2.64 | 6.13 | 0.73 | 3.84 | 17.35 |
Net Debt / FCF Ratio | 3.51 | 5.38 | 17.48 | 0.99 | -5.46 | 9.28 |
Asset Turnover | 0.58 | 0.55 | 0.50 | 0.63 | 0.60 | 0.60 |
Inventory Turnover | 3.10 | 3.03 | 2.59 | 3.00 | 3.34 | 2.74 |
Quick Ratio | 1.80 | 1.60 | 1.40 | 1.75 | 1.77 | 0.28 |
Current Ratio | 2.74 | 2.59 | 2.35 | 2.65 | 2.58 | 0.43 |
Return on Equity (ROE) | 4.97% | 5.58% | 2.61% | 2.47% | 17.96% | -28.09% |
Return on Assets (ROA) | 3.99% | 4.07% | 2.37% | 2.57% | -0.47% | 0.39% |
Return on Invested Capital (ROIC) | 5.79% | 6.01% | 2.66% | 3.31% | -1.08% | 1.02% |
Return on Capital Employed (ROCE) | 7.10% | 7.30% | 3.40% | 4.60% | -0.80% | 0.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 2.55% | 3.67% | 1.86% | 2.66% | 10.51% | -25.50% |
FCF Yield | 7.38% | 7.34% | 3.19% | 9.36% | -3.16% | 55.89% |
Buyback Yield / Dilution | -4.40% | -9.26% | -0.85% | -85.72% | -19.91% | -2.68% |